Additionally, mutations in epigenetic modifier genes such as TET2, ASXL1, DNMT3A, and EZH2 occur frequently in MPN cases, with reported frequencies ranging from 1% to 30% [20]. The gene discussed is EZH2; the disease is myeloproliferative neoplasm.